Markets.News

INSM  INSMED INC

+ add to watchlist

$201.15

insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. the company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. headquartered in bridgewater, nj, we are a rapidly growing company with offices in seven countries.

Mkt Cap: $42B

52 Week High: $212.75

P/E: -16.37

52 Week Low: $60.40

Dividend: $0.00

Shares Outstanding: 213.27M

This news is delayed by 15 minutes, sign up now to get live news & full features.